Number of the records: 1
Dendritic cell-based immunotherapy (DCVAC/OvCa) withchemotherapy in patients with platinum-sensitive, relapsed,epithelial ovarian carcinoma: Survival analysis of a phase II,open-label, randomized, multicenter trial (study SOV02)
- 1.
SYSNO 0506303 Title Dendritic cell-based immunotherapy (DCVAC/OvCa) withchemotherapy in patients with platinum-sensitive, relapsed,epithelial ovarian carcinoma: Survival analysis of a phase II,open-label, randomized, multicenter trial (study SOV02) Author(s) Cibula, D. (CZ)
Rob, L. (CZ)
Mallmann, P. (DE)
Knapp, P. (PL)
Bartůňková, J. (CZ)
Spíšek, R. (CZ)
Hassan, H. I. (CZ)
Pecen, Ladislav (UIVT-O) RID, SAI, ORCID
Klat, J. (CZ)
Chovanec, J. (CZ)Source Title Gynecologic Oncology. Roč. 154, suppl. 1 (2019), s. 18-18. - : Elsevier Conference Annual Meeting of the Society of Gynecologic Oncology /50./, 16.03.2019 - 19.03.2019, Honolulu Document Type Abstrakt Institutional support UIVT-O - RVO:67985807 Language eng Country US Permanent Link http://hdl.handle.net/11104/0297589
Number of the records: 1